Research
Mixed
The Obesity Lifecycle Model demonstrates favorable concordance with observed clinical and quality-of-life outcomes, validating its use for evaluating obesity-related complications and informing healthcare decision making.
Healthcare decision-makers can use the Obesity Lifecycle Model to assess the cost-effectiveness of obesity therapies with confidence, as it has been validated to accurately predict clinical complications and quality-of-life impacts.
GoodSupportsHIGH confidence
The Obesity Lifecycle Model demonstrates favourable concordance with observed clinical and quality-of-life outcomes, supporting its use for evaluating obesity-related complications and informing healthcare decision making.
Why this rating
The study performs rigorous external and cross-validation against multiple datasets, showing high R2 values and low mean error for key endpoints.
Source
Validation of the Obesity Lifecycle Model Built to Assess the Cost Effectiveness of Novel Therapies in the Management of Obesity
B Modley et al. · PharmacoEconomics - Open · 2026
DOI 10.1007/s41669-026-00661-y
unknown
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →